GOA Therapeutics Corp
About GOA Therapeutics Corp
GOA Therapeutics Corporation is a research-stage, preclinical biotechnology company dedicated to developing therapeutic product candidates. The company is currently in the preclinical stage and has not received regulatory approval to conduct human testing or commercialize its product candidates. Research and development activities are focused on establishing the foundation for future clinical trials, regulatory submissions, and commercialization. The company recognized research and development expense of $971,289 and $700,845 for the six months ended June 30, 2026 and 2025, respectively.
- 🔗 offering circular
- 🔗 Goa Antibiotics & Pharmaceuticals 2026 Company Profile: Valuation, Investors, Acquisition | PitchBook
- 🔗 GOA Therapeutics Corp
- 🔗 GOA ANTIBIOTICS AND PHARMACEUTICALS LIMITED - 2026 Company Profile & Financials - Tracxn
- 🔗 Planet Hollywood Goa - 2026 Company Profile & Competitors - Tracxn
Investors
Key highlights
- GOA Therapeutics Corp completed a $300,000 private placement.
- Company remains in preclinical stage with R&D spend of $971,289 in first half of 2026.
- Focuses on building foundation for future clinical trials and regulatory submissions.
- LinkedIn presence shows 14 followers under goathera handle.
Ask StreetZero about GOA Therapeutics Corp
Put our AI to work on this deal.
Similar companies
Other Pharmaceuticals deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account